JPS5777697A - Physiologically active substance nsq - Google Patents
Physiologically active substance nsqInfo
- Publication number
- JPS5777697A JPS5777697A JP55155486A JP15548680A JPS5777697A JP S5777697 A JPS5777697 A JP S5777697A JP 55155486 A JP55155486 A JP 55155486A JP 15548680 A JP15548680 A JP 15548680A JP S5777697 A JPS5777697 A JP S5777697A
- Authority
- JP
- Japan
- Prior art keywords
- agent
- various kinds
- extracted
- substance
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55155486A JPS5777697A (en) | 1980-11-04 | 1980-11-04 | Physiologically active substance nsq |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55155486A JPS5777697A (en) | 1980-11-04 | 1980-11-04 | Physiologically active substance nsq |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5777697A true JPS5777697A (en) | 1982-05-15 |
| JPS6325600B2 JPS6325600B2 (ja) | 1988-05-26 |
Family
ID=15607090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55155486A Granted JPS5777697A (en) | 1980-11-04 | 1980-11-04 | Physiologically active substance nsq |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5777697A (ja) |
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6429389A (en) * | 1987-07-23 | 1989-01-31 | Nippon Zoki Pharmaceutical Co | Novel physiologically active substance and production thereof |
| JPH0228115A (ja) * | 1988-04-30 | 1990-01-30 | Nippon Zoki Pharmaceut Co Ltd | 生理活性物質及び該物質を含有する医薬組成物 |
| US5534509A (en) * | 1993-03-19 | 1996-07-09 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition regulating function of a living body |
| US5560935A (en) * | 1993-09-28 | 1996-10-01 | Nippon Zoki Pharmaceutical Co., Ltd. | Physiologically active substances extracted from activated tissues |
| US5599683A (en) * | 1993-08-06 | 1997-02-04 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for measuring production activity of test substance towards FXIIa |
| US5648228A (en) * | 1993-08-06 | 1997-07-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Measuring activity toward production of activated blood coagulation factor XII, plasma kallikrein or bradykinin using reconstituted kallikrein-kinin system |
| EP0852950A1 (en) * | 1997-01-08 | 1998-07-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Nitrogen monoxide production suppressor |
| JP2001058949A (ja) * | 1999-08-20 | 2001-03-06 | Fujimoto Brothers:Kk | 抗ショック剤 |
| US6365192B1 (en) | 1999-04-15 | 2002-04-02 | Nippon Zoki Pharmaceutical Co., Ltd. | Bioactivating substance |
| US6541041B1 (en) | 1997-11-28 | 2003-04-01 | Nippon Zoki Pharmaceutical Co., Ltd. | Crude drug extracts, and methods for making and standardizing same |
| US6726932B2 (en) | 2000-02-18 | 2004-04-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Fatty acid-containing composition |
| US6913900B2 (en) | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
| US8293280B2 (en) | 2004-12-17 | 2012-10-23 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for treatment of HIV infection |
| US8568789B2 (en) | 2004-12-01 | 2013-10-29 | Nippon Zoki Pharmaceutical Co., Ltd. | Dried product and a process for manufacturing the product |
| JP2017505316A (ja) * | 2014-02-07 | 2017-02-16 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 抗精神病薬物およびｖｍａｔ２阻害剤を含む医薬組成物およびその使用 |
| US9884077B2 (en) | 2013-04-30 | 2018-02-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Extract and preparation containing said extract |
| US10844058B2 (en) | 2015-10-30 | 2020-11-24 | Neurocrine Biosciences, Inc. | Valbenazine salts and polymorphs thereof |
| US10857148B2 (en) | 2017-10-10 | 2020-12-08 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US10857137B2 (en) | 2017-01-27 | 2020-12-08 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US10906903B2 (en) | 2015-12-23 | 2021-02-02 | Neurocrine Biosciences, Inc. | Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) |
| US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US10993941B2 (en) | 2017-10-10 | 2021-05-04 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US11026939B2 (en) | 2017-09-21 | 2021-06-08 | Neurocrine Biosciences, Inc. | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| US11026931B2 (en) | 2018-08-15 | 2021-06-08 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
-
1980
- 1980-11-04 JP JP55155486A patent/JPS5777697A/ja active Granted
Cited By (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6429389A (en) * | 1987-07-23 | 1989-01-31 | Nippon Zoki Pharmaceutical Co | Novel physiologically active substance and production thereof |
| JPH0228115A (ja) * | 1988-04-30 | 1990-01-30 | Nippon Zoki Pharmaceut Co Ltd | 生理活性物質及び該物質を含有する医薬組成物 |
| US5658896A (en) * | 1993-03-19 | 1997-08-19 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition regulating function of a living body |
| US5534509A (en) * | 1993-03-19 | 1996-07-09 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition regulating function of a living body |
| US5807951A (en) * | 1993-03-19 | 1998-09-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition regulating function of a living body |
| US5599683A (en) * | 1993-08-06 | 1997-02-04 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for measuring production activity of test substance towards FXIIa |
| US5648228A (en) * | 1993-08-06 | 1997-07-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Measuring activity toward production of activated blood coagulation factor XII, plasma kallikrein or bradykinin using reconstituted kallikrein-kinin system |
| US5560935A (en) * | 1993-09-28 | 1996-10-01 | Nippon Zoki Pharmaceutical Co., Ltd. | Physiologically active substances extracted from activated tissues |
| EP0852950A1 (en) * | 1997-01-08 | 1998-07-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Nitrogen monoxide production suppressor |
| US6051613A (en) * | 1997-01-08 | 2000-04-18 | Nippon Zoki Pharmaceutical Co., Ltd. | Nitrogen monoxide production suppressor |
| US6541041B1 (en) | 1997-11-28 | 2003-04-01 | Nippon Zoki Pharmaceutical Co., Ltd. | Crude drug extracts, and methods for making and standardizing same |
| US6576241B2 (en) | 1997-11-28 | 2003-06-10 | Nippon Zoki Pharmaceutical Co., Ltd. | Crude drug extracts, and methods for making and standardizing same |
| US6365192B1 (en) | 1999-04-15 | 2002-04-02 | Nippon Zoki Pharmaceutical Co., Ltd. | Bioactivating substance |
| JP2001058949A (ja) * | 1999-08-20 | 2001-03-06 | Fujimoto Brothers:Kk | 抗ショック剤 |
| US6726932B2 (en) | 2000-02-18 | 2004-04-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Fatty acid-containing composition |
| US6913900B2 (en) | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
| US8568789B2 (en) | 2004-12-01 | 2013-10-29 | Nippon Zoki Pharmaceutical Co., Ltd. | Dried product and a process for manufacturing the product |
| US8293280B2 (en) | 2004-12-17 | 2012-10-23 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for treatment of HIV infection |
| US9884077B2 (en) | 2013-04-30 | 2018-02-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Extract and preparation containing said extract |
| JP2017505316A (ja) * | 2014-02-07 | 2017-02-16 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 抗精神病薬物およびｖｍａｔ２阻害剤を含む医薬組成物およびその使用 |
| US10851104B2 (en) | 2015-10-30 | 2020-12-01 | Neurocrine Biosciences, Inc. | Valbenazine salts and polymorphs thereof |
| US10851103B2 (en) | 2015-10-30 | 2020-12-01 | Neurocrine Biosciences, Inc. | Valbenazine salts and polymorphs thereof |
| US10844058B2 (en) | 2015-10-30 | 2020-11-24 | Neurocrine Biosciences, Inc. | Valbenazine salts and polymorphs thereof |
| US10906903B2 (en) | 2015-12-23 | 2021-02-02 | Neurocrine Biosciences, Inc. | Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) |
| US10919892B2 (en) | 2015-12-23 | 2021-02-16 | Neurocrine Biosciences, Inc. | Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) |
| US10906902B2 (en) | 2015-12-23 | 2021-02-02 | Neurocrine Biosciences, Inc. | Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) |
| US10912771B1 (en) | 2017-01-27 | 2021-02-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US10874648B2 (en) | 2017-01-27 | 2020-12-29 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US10857137B2 (en) | 2017-01-27 | 2020-12-08 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US10952997B2 (en) | 2017-01-27 | 2021-03-23 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US11040029B2 (en) | 2017-01-27 | 2021-06-22 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US11439629B2 (en) | 2017-01-27 | 2022-09-13 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US11026939B2 (en) | 2017-09-21 | 2021-06-08 | Neurocrine Biosciences, Inc. | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| US11311532B2 (en) | 2017-09-21 | 2022-04-26 | Neurocrine Biosciences, Inc. | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| US10857148B2 (en) | 2017-10-10 | 2020-12-08 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US10993941B2 (en) | 2017-10-10 | 2021-05-04 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US11654142B2 (en) | 2017-10-10 | 2023-05-23 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US11026931B2 (en) | 2018-08-15 | 2021-06-08 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6325600B2 (ja) | 1988-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5777697A (en) | Physiologically active substance nsq | |
| Dorner et al. | Cyclopiazonic acid production by Aspergillus flavus and its effects on broiler chickens | |
| Boyland et al. | The metabolism of tryptophan. 2. The metabolism of tryptophan in patients suffering from cancer of the bladder | |
| Chanayath et al. | Pigment extraction techniques from the leaves of Indigofera tinctoria Linn. and Baphicacanthus cusia Brem. and chemical structure analysis of their major components | |
| HIKINO et al. | Antiinflammatory principles of Aconitum roots | |
| JPS6339572B2 (ja) | ||
| Galzigna et al. | Physical and biochemical changes of thermal mud after maturation | |
| ZA876322B (en) | Lipases and lipase extracts,their preparation process and their therapeutic use | |
| CN103695516B (zh) | 大鲵提取物及其制备方法 | |
| Lee et al. | Metabolism of carbonyl-labeled 14C-biotin in the rat | |
| HUT54989A (en) | Process for producing disubstituted (quinolin-2-ylmethoxy)-phenylacetic acid derivatives and pharmaceutical compositions comprising same | |
| JPS57206384A (en) | Cultivating method of cell | |
| CA2460460A1 (en) | Fermentation product of cryptoporus volvatus and its preparation method and use | |
| Radomski | The absorption, fate and excretion of citrus red no. 2 (2, 5-dimethoxyphenyl-azo-2-naphthol) and ext. D&C red no. 14 (1-xylylazo-2-naphthol) | |
| CN101444559B (zh) | 清热解毒、利尿通淋的颗粒剂及其制备方法和检测方法 | |
| Gruen | The production of indoleacetic acid by Phycomyces blakesleeanus | |
| JPS5712999A (en) | Antibiral agent and its preparation | |
| JPS57150350A (en) | Formula feed for lugworm | |
| ATE16897T1 (de) | Verfahren zur herstellung eines anionenaustauschers und dessen verwendung. | |
| CN103990144B (zh) | 一种钩吻生物碱的包合物及其制备方法和应用 | |
| JPS5659702A (en) | Rearing agent of good rice plant seedling | |
| Schoenhard et al. | Preparation of 14C-labeled aflatoxin B1 | |
| JPS559021A (en) | Physiologically active substance from japanese ginger, its preparation, and drug comprising it | |
| JPS572297A (en) | Moranoline derivative and its preparation | |
| Dicuollo et al. | The Metabolism of 3-[(5-methyl-5H-as-triazino [5, 6-b]-indol-3-yl) amino]-1-propanol (SK & F 21687): A Potent Antiviral |